(Q44271861)

1 December 2017

title

In vitro characterization of a human calcitonin receptor gene polymorphism (English)

1 reference

1 December 2017

Lawrence A Wolfe

1

1 reference

1 December 2017

Mary E Fling

2

1 reference

1 December 2017

Zhengyu Xue

3

1 reference

1 December 2017

Susan Armour

4

1 reference

1 December 2017

Sandra A Kerner

5

1 reference

1 December 2017

James Way

6

1 reference

1 December 2017

Tom Rimele

7

1 reference

1 December 2017

Richard F Cox

8

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

1 December 2017

1 reference

1 December 2017

volume

522

1 reference

1 December 2017

issue

1-2

1 reference

1 December 2017

page(s)

93-105

1 reference

Evidence for calcitonin--a new hormone from the parathyroid that lowers blood calcium

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900282-8

FURTHER EVIDENCE FOR CALCITONIN. A RAPID-ACTING HORMONE WHICH LOWERS PLASMA-CALCIUM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900282-8

Inhibition by calcitonin of bone resorption induced in vitro by vitamin A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900282-8

Ultrastructural effects of calcitonin on osteoclasts in tissue culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900282-8

Pharmacological control of osteoclastic motility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900282-8

Effects of parathyroid hormone and calcitonin on osteoclast formation in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900282-8

The Sensitivity of Isolated Osteoclasts to Morphological Transformation by Calcitonin*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900282-8

Thyrocalcitonin: inhibitor of bone resorption in tissue culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900282-8

Thyrocalcitonin inhibition of bone resorption induced by parathyroid hormone in tissue culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900282-8

Comparison between the effects of forskolin and calcitonin on bone resorption and osteoclast morphology in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900282-8

Calcitonin-induced changes in the cytoskeleton are mediated by a signal pathway associated with protein kinase A in osteoclasts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900282-8

Evidence that protein kinase-A, calcium-calmodulin kinase and cytoskeletal proteins are involved in osteoclast retraction induced by calcitonin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900282-8

Control of Cyclic Adenosine 3′,5′-Monophosphate Production in Osteoclasts: Calcitonin-Induced Persistent Activation and Homologous Desensitization of Adenylate Cyclase*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900282-8

Expression of two human skeletal calcitonin receptor isoforms cloned from a giant cell tumor of bone. The first intracellular domain modulates ligand binding and signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900282-8

Molecular cloning and functional expression of a third isoform of the human calcitonin receptor and partial characterization of the calcitonin receptor gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900282-8

Efficacy and tolerability of calcitonin in the prevention and treatment of osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900282-8

Response of Paget's disease to porcine and salmon calcitonins: effects of long-term treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900282-8

The clinical and metabolic effects of porcine calcitonin on Paget's disease of bone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900282-8

Effect of calcitonin and glutocorticoids in combination on the hypercalcemia of malignancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900282-8

The effects of calcitonin in hypercalcemia in patients with malignancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900282-8

Calcitonin treatment of hypercalcemia due to parathyroid carcinoma. Synergistic effect of prednisone on long-term treatment of hypercalcemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900282-8

Incidence of Osteoporosis in Elderly Whites and Elderly Negroes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900282-8

Risk for osteoporosis in black women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900282-8

Bone loss in Great Britain and Japan: a comparative longitudinal study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900282-8

Allelic variants of human calcitonin receptor in the Japanese population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900282-8

Allelic variants of human calcitonin receptor: distribution and association with bone mass in postmenopausal Italian women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900282-8

Calcitonin receptor polymorphism is associated with a decreased fracture risk in post-menopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900282-8

Genetic variations and polymorphisms of G protein-coupled receptors: functional and therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900282-8

Interethnic differences in hip fracture rate and the vitamin D receptor polymorphism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900282-8

Vitamin D receptor polymorphism, bone mineral density, and osteoporotic vertebral fracture: studies in a UK population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900282-8

Vitamin D receptor gene polymorphisms are not related to bone turnover, rate of bone loss, and bone mass in postmenopausal women: the OFELY Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900282-8

The contribution of vitamin D receptor gene alleles to the determination of bone mineral density in normal and osteoporotic women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900282-8

Association of bone mineral density with polymorphism of the estrogen receptor gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900282-8

Vitamin D and estrogen receptor allelic variants in Italian postmenopausal women: evidence of multiple gene contribution to bone mineral density.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900282-8

Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I alpha 1 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900282-8

Association of CTR and COLIA1 Alleles with BMD Values in Peri- and Postmenopausal Women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900282-8

Polymorphisms of the interleukin-6 gene are associated with bone mineral density

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900282-8

Association of a polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900282-8

A sequence variation: 713-8delC in the transforming growth factor-beta 1 gene has higher prevalence in osteoporotic women than in normal women and is associated with very low bone mass in osteoporotic women and increased bone turnover in both osteop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900282-8

Signal transduction by GABA(B) receptor heterodimers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900282-8

Molecular tinkering of G protein-coupled receptors: an evolutionary success

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900282-8

G protein-coupled-receptor cross-talk: the fine-tuning of multiple receptor-signalling pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900282-8

ABCA1 regulatory variants influence coronary artery disease independent of effects on plasma lipid levels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900282-8

Polymorphisms of the tumour necrosis factor-alpha gene, coronary heart disease and obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900282-8

Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2802%2900282-8

10.1016/S0027-5107(02)00282-8

7 January 2021

Identifiers

DOI

1 reference

1 December 2017

1 reference